Lapatinib versus lapatinib plus capecitabine as second-line treatment in HER-2-overexpressing metastatic gastroesophageal cancer (GC): A randomized phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Lorenzen, Sylvie and Riera-Knorrenschild, Jorge and Haag, Georg Martin and Pohl, Michael and Thuss-Patience, Peter C. and Bassermann, Florian and Helbig, Ulrike and Weissinger, Florian and Schnoy, Elisabeth and Becker, Klaus and Stocker, Gertraud and Ruschoff, Josef and Eisenmenger, Andreas and Karapanagiotou-Schenkel, Irini and Lordick, Florian (2015) Lapatinib versus lapatinib plus capecitabine as second-line treatment in HER-2-overexpressing metastatic gastroesophageal cancer (GC): A randomized phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO). JOURNAL OF CLINICAL ONCOLOGY, 33 (3suppl): 112. ISSN 0732-183X, 1527-7755

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 14 Aug 2020 10:32
Last Modified: 14 Aug 2020 10:32
URI: https://pred.uni-regensburg.de/id/eprint/6088

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.